Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/3973
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorHAJJAR, Ludhmila A.-
dc.contributor.authorALMEIDA, Juliano P.-
dc.contributor.authorFUKUSHIMA, Julia T.-
dc.contributor.authorRHODES, Andrew-
dc.contributor.authorVINCENT, Jean-Louis-
dc.contributor.authorOSAWA, Eduardo A.-
dc.contributor.authorGALAS, Filomena R. B. G.-
dc.date.accessioned2014-01-28T22:19:28Z-
dc.date.available2014-01-28T22:19:28Z-
dc.date.issued2013-
dc.identifier.citationJOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, v.146, n.2, p.455-460, 2013-
dc.identifier.issn0022-5223-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/3973-
dc.description.abstractObjective: Although hyperlactatemia after cardiac surgery is common, the implications of raised levels remain controversial. The aim of this study was to evaluate whether high lactate levels after cardiac surgery are predictors of major complications including mortality. Patients and Methods: This was a substudy of TRACS (Transfusion Requirements After Cardiac Surgery), which was designed as a prospective, randomized, controlled trial evaluating the effects of a transfusion strategy on morbidity and mortality. Results: Of the 502 patients enrolled, 52 (10%) had at least 1 major complication. Patients with complications were older, had a higher EuroSCORE, lower left ventricular ejection fraction, lower preoperative hemoglobin, a higher prevalence of renal disease, and received more blood transfusions than the group without complications. Lactate levels were higher in the group with complications at the end of surgery (3.6 mmol/L [2.8-5.1] vs 3.3 mmol/L [2.2-4.8]; P = .018), immediately after intensive care unit (ICU) admission (0 hour) (4.4 mmol/L [3.1-8.4] vs 4 mmol/L [2.6-6.4]; P = .048); 6 hours (4 mmol/L [2.7-5.8] vs 2.6 mmol/L [2-3.6], P < .001), and 12 hours after admission (2.3 mmol/L [1.8-3.2] vs 1.7 mmol/L [1.3-2]; P < .001). In a multivariate model, higher age (odds ratio [OR], 1.048, 95% confidence interval [CI], 1.011-1.086; P = .010), left ventricular ejection fraction (LVEF) lower than 40% (OR, 3.03; 95% CI, 1.200-7.510; P = .019 compared with LVEF of 40%-59%; OR, 3.571; 95% CI, 1.503-8.196; P = .004 compared with LVEF higher than 60%), higher EuroSCORE (OR, 1.138; 95% CI; 1.007-1.285; P = .038), red blood cell transfusion (OR, 1.230; 95% CI, 1.086-1.393; P = .001), and lactate levels 6 hours after ICU admission (OR, 3.28, 95% CI; 1.61-6.69; P = .001) are predictors of major complications. Conclusions: Hyperlactatemia 6 hours after ICU admission is an independent risk factor for worse outcomes in adult patients after cardiac surgery.-
dc.language.isoeng-
dc.publisherMOSBY-ELSEVIER-
dc.relation.ispartofJournal of Thoracic and Cardiovascular Surgery-
dc.rightsrestrictedAccess-
dc.subject.othercritically-ill patients-
dc.subject.otherrandomized controlled-trial-
dc.subject.othercardiopulmonary bypass-
dc.subject.otherrisk-factors-
dc.subject.otherhyperlactatemia-
dc.subject.othermortality-
dc.subject.othertransfusion-
dc.subject.otheroutcomes-
dc.titleHigh lactate levels are predictors of major complications after cardiac surgery-
dc.typearticle-
dc.rights.holderCopyright MOSBY-ELSEVIER-
dc.identifier.doi10.1016/j.jtcvs.2013.02.003-
dc.identifier.pmid23507124-
dc.subject.wosCardiac & Cardiovascular Systems-
dc.subject.wosRespiratory System-
dc.subject.wosSurgery-
dc.type.categoryoriginal article-
dc.type.versionpublishedVersion-
hcfmusp.author.externalRHODES, Andrew:St Georges Healthcare NHS Trust, Dept Crit Care, London, England; St Georges Univ London, London, England-
hcfmusp.author.externalVINCENT, Jean-Louis:Univ Libre Brussels, Erasme Hosp, Dept Intens Care, Brussels, Belgium-
hcfmusp.description.beginpage455-
hcfmusp.description.endpage460-
hcfmusp.description.issue2-
hcfmusp.description.volume146-
hcfmusp.origemWOS-
hcfmusp.origem.id2-s2.0-84880319795-
hcfmusp.origem.idWOS:000322635400032-
hcfmusp.publisher.cityNEW YORK-
hcfmusp.publisher.countryUSA-
hcfmusp.relation.referenceBakker J, 2004, CRIT CARE, V8, P96, DOI 10.1186/cc2841-
hcfmusp.relation.referenceBellomo R, 2002, CRIT CARE, V6, P322-
hcfmusp.relation.referenceBERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818-
hcfmusp.relation.referenceCheung PY, 2005, J THORAC CARDIOV SUR, V130, P837, DOI 10.1016/j.jtcvs.2005.04.029-
hcfmusp.relation.referenceFerraris VA, 2007, ANN THORAC SURG, V83, P27, DOI 10.1016/j.athoracsur.2007.02.099-
hcfmusp.relation.referenceHaase M, 2009, J THORAC CARDIOV SUR, V138, P1370, DOI 10.1016/j.jtcvs.2009.07.007-
hcfmusp.relation.referenceHajjar LA, 2010, JAMA-J AM MED ASSOC, V304, P1559, DOI 10.1001/jama.2010.1446-
hcfmusp.relation.referenceHajjar LA, 2011, CLINICS, V66, P2037, DOI 10.1590/S1807-59322011001200007-
hcfmusp.relation.referenceHannan EL, 2003, JAMA-J AM MED ASSOC, V290, P773, DOI 10.1001/jama.290.6.773-
hcfmusp.relation.referenceKhosravani H, 2009, CRIT CARE, V13, DOI 10.1186/cc7918-
hcfmusp.relation.referenceLEAVY JA, 1988, JAMA-J AM MED ASSOC, V260, P662, DOI 10.1001/jama.260.5.662-
hcfmusp.relation.referenceLevy B, 2006, CURR OPIN CRIT CARE, V12, P315, DOI 10.1097/01.ccx.0000235208.77450.15-
hcfmusp.relation.referenceLi J, 2000, J THORAC CARDIOV SUR, V119, P525, DOI 10.1016/S0022-5223(00)70132-2-
hcfmusp.relation.referenceMaillet JM, 2003, CHEST, V123, P1361, DOI 10.1378/chest.123.5.1361-
hcfmusp.relation.referenceMangano CM, 1998, ANN INTERN MED, V128, P194-
hcfmusp.relation.referenceMassé Linda, 2005, Crit Care Nurs Clin North Am, V17, P375, DOI 10.1016/j.ccell.2005.07.005-
hcfmusp.relation.referenceMcKendry M, 2004, BRIT MED J, V329, P258, DOI 10.1136/bmj.38156.767118.7C-
hcfmusp.relation.referenceMcNelis J, 2001, AM J SURG, V182, P481, DOI 10.1016/S0002-9610(01)00755-3-
hcfmusp.relation.referenceMunoz R, 2000, J THORAC CARDIOV SUR, V119, P155, DOI 10.1016/S0022-5223(00)70231-5-
hcfmusp.relation.referenceNichol AD, 2010, CRIT CARE, V14, DOI 10.1186/cc8888-
hcfmusp.relation.referenceO'Connor ED, 2010, CRIT CARE, V14, DOI 10.1186/cc9017-
hcfmusp.relation.referencePietersen HG, 1999, J THORAC CARDIOV SUR, V118, P71, DOI 10.1016/S0022-5223(99)70143-1-
hcfmusp.relation.referencePolonen P, 2000, ANESTH ANALG, V90, P1052-
hcfmusp.relation.referenceRaper RF, 1997, CRIT CARE MED, V25, P46, DOI 10.1097/00003246-199701000-00011-
hcfmusp.relation.referenceRoques F, 1999, EUR J CARDIO-THORAC, V15, P816, DOI 10.1016/S1010-7940(99)00106-2-
hcfmusp.relation.referenceSTAINSBY WN, 1987, J APPL PHYSIOL, V62, P1845-
hcfmusp.relation.referenceTakala J, 1996, New Horiz, V4, P483-
hcfmusp.relation.referenceValenza F, 2005, CRIT CARE, V9, P588, DOI 10.1186/cc3818-
dc.description.indexMEDLINE-
hcfmusp.citation.scopus122-
hcfmusp.scopus.lastupdate2024-04-12-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MCP
Departamento de Cardio-Pneumologia - FM/MCP

Artigos e Materiais de Revistas Científicas - HC/ICESP
Instituto do Câncer do Estado de São Paulo - HC/ICESP

Artigos e Materiais de Revistas Científicas - HC/InCor
Instituto do Coração - HC/InCor

Artigos e Materiais de Revistas Científicas - LIM/08
LIM/08 - Laboratório de Anestesiologia

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar


Files in This Item:
File Description SizeFormat 
art_HAJJAR_High_lactate_levels_are_predictors_of_major_complications_2013.PDF
  Restricted Access
publishedVersion (English)228.57 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.